JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHA:600200)

SHA:600200 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	168.48	1,152	1,713	1,477	1,131	683.6
Short-Term Investments	-	-	-	170.57	173.83	80
Trading Asset Securities	-	-	-	-	-	40.01
Cash & Short-Term Investments	168.48	1,152	1,713	1,648	1,305	803.61
Cash Growth	-89.83%	-32.77%	3.96%	26.28%	62.36%	-9.83%
Accounts Receivable	2,172	1,485	1,136	867.68	763.86	1,239
Other Receivables	15.26	5.84	16.86	59.83	12.39	7.83
Receivables	2,187	1,491	1,153	927.51	776.25	1,247
Inventory	94.93	93.96	107.26	112.62	126.45	154.82
Prepaid Expenses	-	0.36	0.01	0.74	0	-
Other Current Assets	304.24	16.36	28.59	41.06	476.85	475.01
Total Current Assets	2,755	2,753	3,001	2,730	2,684	2,680
Property, Plant & Equipment	244.21	252.01	261.15	231.01	251.52	294.45
Long-Term Investments	437.07	436.98	697.89	626.31	511.06	446.43
Goodwill	122.34	122.34	-	-	-	-
Other Intangible Assets	141.25	143.22	118.43	101.59	111.09	61.21
Long-Term Deferred Tax Assets	42.07	31.97	5.87	2.89	3.42	2.79
Long-Term Deferred Charges	140.9	137.99	121.76	106.81	84.53	99.24
Other Long-Term Assets	94.98	97.52	120.58	111.7	112.41	119.48
Total Assets	3,978	3,975	4,327	3,910	3,758	3,704
Accounts Payable	157.31	119.03	271.51	237.34	149.54	237.55
Accrued Expenses	23.12	63.14	43.46	48.57	35.96	39.83
Short-Term Debt	1,304	1,341	1,583	1,370	1,116	1,051
Current Portion of Long-Term Debt	110.83	106.03	38.06	32.05	62	20.01
Current Portion of Leases	-	3.08	1.69	0.56	1.1	-
Current Income Taxes Payable	36.16	17.88	14.47	14.16	15.54	4.96
Current Unearned Revenue	130.03	47.23	28.72	24.8	67.5	68.55
Other Current Liabilities	103.81	107.47	397.96	128	248.08	173.5
Total Current Liabilities	1,865	1,805	2,379	1,856	1,696	1,595
Long-Term Debt	203.25	181.21	127.17	165.25	167.24	229.22
Long-Term Leases	13.38	13.7	13.54	-	0.56	-
Long-Term Unearned Revenue	3.56	3.72	4.5	5.31	7.21	14.08
Long-Term Deferred Tax Liabilities	8.36	8.44	8.99	6.14	6.05	-
Other Long-Term Liabilities	61.11	73.78	32.24	54.09	4.53	13.28
Total Liabilities	2,154	2,086	2,565	2,086	1,881	1,852
Common Stock	712.15	712.2	712.29	712.39	712.39	712.39
Additional Paid-In Capital	1,416	1,415	1,412	1,404	1,403	1,403
Retained Earnings	-370.05	-299.74	-370.22	-298.28	-222.11	-217.05
Treasury Stock	-4.68	-4.93	-10.02	-15.12	-40.04	-40.04
Comprehensive Income & Other	-0.24	0.11	-0.24	0.17	1.62	-10.6
Total Common Equity	1,753	1,823	1,744	1,804	1,855	1,848
Minority Interest	70.43	65.93	17.43	19.87	21.91	3.99
Shareholders' Equity	1,823	1,889	1,761	1,824	1,877	1,852
Total Liabilities & Equity	3,978	3,975	4,327	3,910	3,758	3,704
Total Debt	1,631	1,645	1,764	1,568	1,347	1,300
Net Cash (Debt)	-1,463	-493.63	-50.79	79.68	-42.22	-496.5
Net Cash Per Share	-2.06	-0.69	-0.07	0.11	-0.06	-0.70
Filing Date Shares Outstanding	710.28	701.12	658.51	722.65	704.56	704.56
Total Common Shares Outstanding	710.28	701.12	658.51	722.65	704.56	704.56
Working Capital	890.14	947.82	622.24	873.99	988.51	1,085
Book Value Per Share	2.47	2.60	2.65	2.50	2.63	2.62
Tangible Book Value	1,489	1,558	1,626	1,702	1,744	1,787
Tangible Book Value Per Share	2.10	2.22	2.47	2.36	2.48	2.54
Buildings	-	308.72	308.72	309.63	311.56	325.27
Machinery	-	366.92	355.86	355.91	359	451.71
Construction In Progress	-	37.64	36.59	6.93	6.04	0.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.